Literature DB >> 36245662

A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology.

Abraham W Aron1, Neera K Dahl1, Whitney Besse1.   

Abstract

Genetic testing is increasingly used in the workup and diagnosis of kidney disease and kidney-related disorders of undetermined cause. Out-of-pocket costs for clinical genetic testing have become affordable, and logistical hurdles overcome. The interest in genetic testing may stem from the need to make or confirm a diagnosis, guide management, or the patient's desire to have a more informed explanation or prognosis. This poses a challenge for providers who do not have formal training in the selection, interpretation, and limitations of genetic tests. In this manuscript, we provide detailed discussion of relevant cases in which clinical genetic testing using a kidney gene panel was applied. The cases demonstrate identification of pathogenic variants for monogenic diseases-contrasting them from genetic risk alleles-and bring up diagnostic limitations and diagnostic utility of these tests in nephrology. This review aims to guide clinicians in formulating pretest conversations with their patients, interpreting genetic variant nomenclature, and considering follow-up investigations. Although providers are gaining experience, there is still risk of testing causing more anxiety than benefit. However, with provider education and support, clinical genetic testing applied to otherwise unexplained kidney-related disorders will increasingly serve as a valuable diagnostic tool with the potential to reshape how we consider and treat many kidney-related diagnoses.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  gene panel; genetic testing; genetics; next-generation sequencing

Mesh:

Year:  2022        PMID: 36245662      PMCID: PMC9528385          DOI: 10.34067/KID.0007552021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  78 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

Review 2.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

3.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

Review 4.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

5.  Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.

Authors:  Jan Halbritter; Michelle Baum; Ann Marie Hynes; Sarah J Rice; David T Thwaites; Zoran S Gucev; Brittany Fisher; Leslie Spaneas; Jonathan D Porath; Daniela A Braun; Ari J Wassner; Caleb P Nelson; Velibor Tasic; John A Sayer; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-08       Impact factor: 10.121

6.  Family history of end-stage renal disease among incident dialysis patients.

Authors:  B I Freedman; J M Soucie; W M McClellan
Journal:  J Am Soc Nephrol       Date:  1997-12       Impact factor: 10.121

7.  Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis.

Authors:  Ankana Daga; Amar J Majmundar; Daniela A Braun; Heon Yung Gee; Jennifer A Lawson; Shirlee Shril; Tilman Jobst-Schwan; Asaf Vivante; David Schapiro; Weizhen Tan; Jillian K Warejko; Eugen Widmeier; Caleb P Nelson; Hanan M Fathy; Zoran Gucev; Neveen A Soliman; Seema Hashmi; Jan Halbritter; Margarita Halty; Jameela A Kari; Sherif El-Desoky; Michael A Ferguson; Michael J G Somers; Avram Z Traum; Deborah R Stein; Ghaleb H Daouk; Nancy M Rodig; Avi Katz; Christian Hanna; Andrew L Schwaderer; John A Sayer; Ari J Wassner; Shrikant Mane; Richard P Lifton; Danko Milosevic; Velibor Tasic; Michelle A Baum; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2017-10-12       Impact factor: 10.612

Review 8.  Genetic discrimination and life insurance: a systematic review of the evidence.

Authors:  Yann Joly; Ida Ngueng Feze; Jacques Simard
Journal:  BMC Med       Date:  2013-01-31       Impact factor: 8.775

9.  Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.

Authors:  Nine Knoers; Corinne Antignac; Carsten Bergmann; Karin Dahan; Sabrina Giglio; Laurence Heidet; Beata S Lipska-Ziętkiewicz; Marina Noris; Giuseppe Remuzzi; Rosa Vargas-Poussou; Franz Schaefer
Journal:  Nephrol Dial Transplant       Date:  2022-01-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.